PGGM Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,274
| Closed | -$13.8M | – | 188 |
|
|
2025
Q1 | $13.8M | Buy |
123,274
+74,751
| +154% | +$7.71M | 0.19% | 110 |
|
|
2024
Q4 | $4.48M | Buy |
+48,523
| New | +$4.37M | 0.06% | 201 |
|
|
2024
Q2 | – | Sell |
-55,034
| Closed | -$4.03M | – | 361 |
|
|
2024
Q1 | $4.03M | Sell |
55,034
-32,033
| -37% | -$2.46M | 0.06% | 206 |
|
|
2023
Q4 | $7.05M | Buy |
87,067
+8,382
| +11% | +$652K | 0.11% | 155 |
|
|
2023
Q3 | $5.9M | Sell |
78,685
-3,646
| -4% | -$280K | 0.1% | 172 |
|
|
2023
Q2 | $6.34M | Sell |
82,331
-1,479
| -2% | -$118K | 0.1% | 177 |
|
|
2023
Q1 | $6.95M | Sell |
83,810
-6,448
| -7% | -$534K | 0.12% | 161 |
|
|
2022
Q4 | $7.75M | Sell |
90,258
-21,607
| -19% | -$1.71M | 0.14% | 143 |
|
|
2022
Q3 | $6.9M | Buy |
+111,865
| New | +$7.05M | 0.12% | 167 |
|
|
2022
Q1 | $67.6M | Hold |
931,032
| – | – | 0.34% | 60 |
|
|
2021
Q4 | $67.6M | Buy |
931,032
+368,450
| +65% | +$25.4M | 0.34% | 60 |
|
|
2021
Q3 | $39.3M | Buy |
562,582
+9,961
| +2% | +$700K | 0.2% | 127 |
|
|
2021
Q2 | $38.1M | Buy |
552,621
+2,673
| +0.5% | +$178K | 0.16% | 145 |
|
|
2021
Q1 | $35.5M | Buy |
549,948
+123,957
| +29% | +$7.99M | 0.15% | 160 |
|
|
2020
Q4 | $24.8M | Sell |
425,991
-1,244,229
| -74% | -$75.1M | 0.11% | 192 |
|
|
2020
Q3 | $106M | Buy |
1,670,220
+192,613
| +13% | +$13.4M | 0.55% | 53 |
|
|
2020
Q2 | $114M | Sell |
1,477,607
-231,074
| -14% | -$17.7M | 0.66% | 47 |
|
|
2020
Q1 | $128M | Sell |
1,708,681
-202,048
| -11% | -$14M | 0.92% | 35 |
|
|
2019
Q4 | $124M | Sell |
1,910,729
-160,362
| -8% | -$10.4M | 0.7% | 41 |
|
|
2019
Q3 | $131M | Buy |
2,071,091
+404,000
| +24% | +$26.4M | 0.63% | 49 |
|
|
2019
Q2 | $113M | Hold |
1,667,091
| – | – | 0.57% | 53 |
|
|
2019
Q1 | $108M | Buy |
1,667,091
+49,000
| +3% | +$3.26M | 0.55% | 52 |
|
|
2018
Q4 | $101M | Buy |
1,618,091
+40,000
| +3% | +$2.8M | 0.59% | 49 |
|
|
2018
Q3 | $122M | Hold |
1,578,091
| – | – | 0.64% | 43 |
|
|
2018
Q2 | $112M | Hold |
1,578,091
| – | – | 0.61% | 45 |
|
|
2018
Q1 | $119M | Hold |
1,578,091
| – | – | 0.67% | 38 |
|
|
2017
Q4 | $113M | Sell |
1,578,091
-348,542
| -18% | -$26.5M | 0.63% | 42 |
|
|
2017
Q3 | $156M | Buy |
1,926,633
+544,286
| +39% | +$41.6M | 0.77% | 34 |
|
|
2017
Q2 | $97.8M | Buy |
1,382,347
+51,440
| +4% | +$3.42M | 0.5% | 49 |
|
|
2017
Q1 | $90.4M | Sell |
1,330,907
-54,262
| -4% | -$3.82M | 0.47% | 50 |
|
|
2016
Q4 | $99.2M | Sell |
1,385,169
-37,381
| -3% | -$2.78M | 0.51% | 43 |
|
|
2016
Q3 | $113M | Buy |
1,422,550
+120,605
| +9% | +$9.8M | 0.56% | 43 |
|
|
2016
Q2 | $109M | Buy |
1,301,945
+215,288
| +20% | +$19.1M | 0.56% | 46 |
|
|
2016
Q1 | $99.8M | Buy |
1,086,657
+126,063
| +13% | +$11.4M | 0.53% | 48 |
|
|
2015
Q4 | $97.2M | Buy |
+960,594
| New | +$100M | 0.51% | 54 |
|
Other funds holding GILD
PGGM Investments's GILD Position: Q2 2025 in Review
PGGM Investments sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 123,274 shares — an estimated $13.8M sold.
PGGM Investments first reported a position in GILD in Q4 2015 and held it in 35 quarters. The position peaked at $156M in Q3 2017. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- PGGM Investments reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- PGGM Investments sold 123,274 Gilead Sciences shares in Q2 2025, an estimated $13.8M.
- PGGM Investments first reported a position in Gilead Sciences in Q4 2015 and held it in 35 quarters.
- PGGM Investments's Gilead Sciences position peaked at $156M in Q3 2017.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on PGGM Investments's 13F filing for Q2 2025, filed 18 Jul 2025.